Awakn Life Sciences Bristol Clinic Receives Care Quality Commission Approval to Begin Treatments in the UK's First Medical Psychedelic Clinic Psychedelics Investing
Universal Ibogaine CEO Dr. Rami Batal: Well Funded to Develop an Innovative Addiction Treatment Model Video Interview
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions Psychedelics Investing
IBN and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for Upcoming Psychedelic Capital Conference Cannabis Investing News
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada Psychedelics Investing
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy Psychedelics Investing
Hollister Biosciences Inc. Announces strategic initiatives including a planned rebrand, executive and board updates Psychedelics Investing
